eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Documenthome » Draft Guidance for Industry and Food and Drug Administration Staff; De Novo Classification Process (Evaluation of Automatic Class III Designation); Availability; Extension of Comment Period

Draft Guidance for Industry and Food and Drug Administration Staff; De Novo Classification Process (Evaluation of Automatic Class III Designation); Availability; Extension of Comment Period

Document ID: FDA-2011-D-0689-0004

Comments

Total: 10
Pew Health Group - Comment
Posted : 01/11/2012     ID ：FDA-2011-D-0689-0006     Agency : FDA

Jan 03,2012 11:59 PM ET
Voisin Consulting Life Sciences - Comment
Posted : 01/11/2012     ID ：FDA-2011-D-0689-0007     Agency : FDA

Jan 03,2012 11:59 PM ET
Medical Imaging & Technology Alliance (MITA) - Comment
Posted : 01/11/2012     ID ：FDA-2011-D-0689-0008     Agency : FDA

Jan 03,2012 11:59 PM ET
Johnson & Johnson - Comment
Posted : 01/11/2012     ID ：FDA-2011-D-0689-0009     Agency : FDA

Jan 03,2012 11:59 PM ET
Orthopedic Surgical Manufacturers Association (OSMA) - Comment
Posted : 01/11/2012     ID ：FDA-2011-D-0689-0010     Agency : FDA

Jan 03,2012 11:59 PM ET
Cook Group Inc. - Comment
Posted : 01/11/2012     ID ：FDA-2011-D-0689-0011     Agency : FDA

Jan 03,2012 11:59 PM ET
Advanced Medical Technology Association (AdvaMed) - Comment
Posted : 01/11/2012     ID ：FDA-2011-D-0689-0012     Agency : FDA

Jan 03,2012 11:59 PM ET
Patient Consumer and Public Health Coalition - Comment
Posted : 01/11/2012     ID ：FDA-2011-D-0689-0013     Agency : FDA

Jan 03,2012 11:59 PM ET
Philips Healthcare - Comment
Posted : 01/12/2012     ID ：FDA-2011-D-0689-0015     Agency : FDA

Jan 03,2012 11:59 PM ET
Orthopedic Surgical Manufacturers Association (OSMA) - Comment
Posted : 01/12/2012     ID ：FDA-2011-D-0689-0016     Agency : FDA

Jan 03,2012 11:59 PM ET